Us Bancorp \De\ G1 Therapeutics, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$5.17 - $16.99 $14,145 - $46,484	2,736 New	2,736 $34,000
Q1 2022 May 11, 2022	SELL	$7.6 - $11.02 $5,867 - $8,507	-772 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$10.16 - $16.17 $4,185 - $6,662	-412 Reduced 34.8%	772 $8,000
Q4 2020 Feb 04, 2021	BUY	$10.99 - $20.4 $13,012 - $24,153	1,184 New	1,184 $21,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.